This document is page 148 of a Cannabis Investment Report produced by Ackrell Capital, LLC in December 2017. It provides business profiles for four companies: FunkSac, Garden State Dispensary, GFarmaLabs, and Gold Coast Extracts. The document bears a Bates stamp 'HOUSE_OVERSIGHT_024784', indicating it was part of a document production to the House Oversight Committee.
| Name | Type | Context |
|---|---|---|
| Ackrell Capital, LLC |
Header and footer of the document
|
|
| FunkSac |
Profiled company in investment report
|
|
| Garden State Dispensary |
Profiled company in investment report
|
|
| GFarmaLabs |
Profiled company in investment report
|
|
| Gold Coast Extracts |
Profiled company in investment report
|
|
| FINRA |
Mentioned in footer regarding Ackrell Capital membership
|
|
| SIPC |
Mentioned in footer regarding Ackrell Capital membership
|
|
| House Oversight Committee |
Implied by Bates stamp 'HOUSE_OVERSIGHT'
|
| Location | Context |
|---|---|
|
Location of FunkSac
|
|
|
Location of Garden State Dispensary
|
|
|
Location of GFarmaLabs
|
|
|
Location of Gold Coast Extracts
|
|
|
Market location for GFarmaLabs
|
"FunkSac is a provider of compliant packaging solutions for the medicinal and recreational cannabis industry."Source
"Garden State Dispensary is a medicinal cannabis dispensary located in New Jersey."Source
"GFarmaLabs is a producer of branded cannabis, cannabis-infused edibles, cannabis concentrates and vaporizer accessories."Source
"Gold Coast Extracts is an extraction consultant and producer of branded cannabis concentrates."Source
Complete text extracted from the document (1,712 characters)
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document